Static outliers for Hereford Medical Group

There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain. At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator, for prescriptions dispensed between April 2021 and August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical method code is openly available on GitHub here.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at ebmdatalab@phc.ox.ac.uk. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

Prescribing where Hereford Medical Group is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Gluten free/low protein drink 8 Foods for special diets 385 0.02 0.00 0.00 14.44
Rabies 1 Vaccines and antisera 33 0.03 0.00 0.00 7.26
Mianserin hydrochloride 5 Tricyclic and related antidepressant drugs 6875 0.00 0.00 0.00 2.64
Triptorelin embonate 49 Prostate cancer and gonadorelin analogues 230 0.21 0.02 0.07 2.53
Dipipanone hydrochloride 10 Opioid analgesics 8263 0.00 0.00 0.00 2.48

Prescribing where Hereford Medical Group is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Other emollient preparations 689 Emollients 933 0.74 0.89 0.07 -2.15
Glycopyrronium bromide 6 Antimuscarinic drugs 78 0.08 0.82 0.36 -2.08
Mometasone furoate 237 Drugs used in nasal allergy 2079 0.11 0.31 0.13 -1.49
Mesalazine (Systemic) 579 Aminosalicylates 1353 0.43 0.64 0.15 -1.45
Asacol 400mg MR gastro-resistant tablets : 60
Asacol 800mg MR gastro-resistant tablets : 95
Pentasa 500mg modified-release tablets : 58
Pentasa 2g modified-release granules sachets : 31
Pentasa 1g modified-release tablets : 112
Salofalk 3g gastro-resistant modified-release gran sachets : 77
Salofalk 500mg suppositories : 2
Pentasa Mesalazine 1g/100ml enema : 1
Salofalk 500mg gast res MR gran sachets : 1
Pentasa 1g suppositories : 27
Mesalazine 1g modified-release granules sachets sugar free : 8
Pentasa 1g modified-release granules sachets : 8
Salofalk 1.5g gastro-resistant modified-release gran sachets : 8
Mesalazine 500mg gastro-resistant tablets : 3
Mesalazine 1g modified-release tablets : 3
Pentasa 4g modified-release granules sachets : 3
Salofalk 2g/59ml enema : 3
Mezavant XL 1200mg tablets : 3
Octasa 800mg MR gastro-resistant tablets : 12
Salofalk 1g/application foam enema : 7
Mesalazine 400mg gastro-resistant tablets : 6
Mesalazine 500mg gast res MR gran sachets sugar free : 6
Mesalazine 1g suppositories : 15
Octasa 400mg MR gastro-resistant tablets : 15
Mesalazine 500mg modified-release tablets : 10
Salofalk 1g suppositories : 5
Letrozole 110 Breast cancer 865 0.13 0.44 0.22 -1.45